ESPINOZA OCTAVIO (Chief Financial Officer) reported 1 transaction at LIGAND PHARMACEUTICALS INC
Review the transaction codes below to understand the nature of each event.
Filed: 12/9/2025ACC: 0002001011-25-000123
Officer· Chief Financial Officer
Since Mar 2026
-1.86K
Net shares
Net seller
$344.2K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
1.86K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−1.86K
Price / share
$184.87
Trade value
$344.23K
% of position
6.2%
12/5/2025
29.85K→27.99K
Total
Net shares
−1.86K
Net value
-$344.23K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/5/2025 | F · Tax Withholding | −1.86K | $184.87 | $344.23K | 6.2% | 29.85K | 27.99K |
| Total | −1.86K | -$344.23K | ||||||
Derivative Transactions0
No derivative transactions reported